Legend Biotech (LEGN) Free Cash Flow (QoQ) (2019 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -136.09% |
| Sep 30, 2025 | 985.44% |
| Jun 30, 2025 | 96.25% |
| Mar 31, 2025 | 5.73% |
| Dec 31, 2024 | -46.33% |
| Sep 30, 2024 | -4,271.78% |
| Jun 30, 2024 | -91.88% |
| Mar 31, 2024 | 116.55% |
| Dec 31, 2023 | -137.00% |
| Sep 30, 2023 | 39.36% |
| Jun 30, 2023 | 32.21% |
| Mar 31, 2023 | -368.30% |
| Dec 31, 2022 | 58.56% |
| Sep 30, 2022 | -6,447.46% |
| Jun 30, 2022 | 98.40% |
| Mar 31, 2022 | 57.40% |
| Dec 31, 2021 | -371.94% |
| Sep 30, 2021 | 24.90% |
| Jun 30, 2021 | -287.43% |
| Mar 31, 2021 | 94.22% |
| Dec 31, 2020 | -243.49% |
| Sep 30, 2020 | -0.69% |
| Jun 30, 2020 | -24.21% |
| Mar 31, 2020 | 23.66% |
| Dec 31, 2019 | -400.73% |
| Sep 30, 2019 | 151.45% |